BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.47B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.89B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$708M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$524M |
| 5 |
Nike
NKE
|
+$468M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
+$293M |
| 3 |
SPDR S&P Retail ETF
XRT
|
+$148M |
| 4 |
NVIDIA
NVDA
|
+$74.9M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$72.9M |
Sector Composition
| 1 | Technology | 17.94% |
| 2 | Consumer Discretionary | 10.22% |
| 3 | Financials | 8.36% |
| 4 | Healthcare | 7.6% |
| 5 | Industrials | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Armstrong World Industries
AWI
$8.5B
| $1.27M | ﹤0.01% |
14,154
+12,734
| +897% | +$1.15M |
|
1502
Omega Healthcare
OHI
$12.6B
| $1.27M | ﹤0.01% |
40,867
-30,469
| -43% | -$949K |
|
1503
Levi Strauss
LEVI
$8.91B
| $1.27M | ﹤0.01% |
64,411
+33,185
| +106% | +$656K |
|
1504
Commercial Metals
CMC
$6.51B
| $1.27M | ﹤0.01% |
30,551
-81,657
| -73% | -$3.4M |
|
1505
iShares Core S&P Total US Stock Market ETF
ITOT
$77B
| $1.27M | ﹤0.01% |
12,540
-149,135
| -92% | -$15.1M |
|
|
MNRL
1506
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $1.26M | ﹤0.01% |
49,500
+15,894
| +47% | +$406K |
|
1507
AquaBounty Technologies
AQB
$4.27M
| $1.26M | ﹤0.01% |
33,809
+15
| +0% | +$561 |
|
1508
Littelfuse
LFUS
$6.56B
| $1.26M | ﹤0.01% |
5,057
+1,314
| +35% | +$328K |
|
1509
H.B. Fuller
FUL
$3.34B
| $1.26M | ﹤0.01% |
19,036
-15,184
| -44% | -$1M |
|
|
BLUE
1510
DELISTED
bluebird bio
BLUE
| $1.26M | ﹤0.01% |
12,966
-1,884
| -13% | -$183K |
|
|
NOAH
1511
Noah Holdings
NOAH
$781M
| $1.26M | ﹤0.01% |
53,407
-2,142
| -4% | -$50.4K |
|
1512
FibroGen
FGEN
$47.8M
| $1.25M | ﹤0.01% |
4,175
-1,317
| -24% | -$396K |
|
1513
Ultragenyx Pharmaceutical
RARE
$2.86B
| $1.25M | ﹤0.01% |
17,249
-29,571
| -63% | -$2.15M |
|
|
ALLK
1514
DELISTED
Allakos
ALLK
| $1.25M | ﹤0.01% |
219,327
+138,030
| +170% | +$787K |
|
1515
Pediatrix Medical
MD
$1.45B
| $1.25M | ﹤0.01% |
53,231
-15,899
| -23% | -$373K |
|
|
PMT
1516
PennyMac Mortgage Investment
PMT
$1.07B
| $1.25M | ﹤0.01% |
73,986
-73,749
| -50% | -$1.25M |
|
1517
Genworth Financial
GNW
$3.6B
| $1.25M | ﹤0.01% |
329,761
-153,504
| -32% | -$580K |
|
1518
OFG Bancorp
OFG
$1.94B
| $1.25M | ﹤0.01% |
46,754
-5,935
| -11% | -$158K |
|
1519
Sturm, Ruger & Co
RGR
$606M
| $1.25M | ﹤0.01% |
17,887
-19,901
| -53% | -$1.39M |
|
|
RCM
1520
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.24M | ﹤0.01% |
46,324
-20,888
| -31% | -$559K |
|
1521
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.3B
| $1.24M | ﹤0.01% |
28,185
-12,357
| -30% | -$543K |
|
1522
BlackLine
BL
$3.39B
| $1.24M | ﹤0.01% |
16,913
+3,898
| +30% | +$285K |
|
1523
Radiant Logistics
RLGT
$316M
| $1.23M | ﹤0.01% |
193,542
-9,983
| -5% | -$63.6K |
|
|
ITCI
1524
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.23M | ﹤0.01% |
20,133
+5,189
| +35% | +$318K |
|
1525
Axsome Therapeutics
AXSM
$5.89B
| $1.23M | ﹤0.01% |
29,756
-42,496
| -59% | -$1.76M |
|